2022 May 15
1.
Endothelial ETS1 inhibition exacerbate blood-brain barrier dysfunction in multiple sclerosis through inducing endothelial-to-mesenchymal transition. Luo Y, Yang H, Wan Y, Yang S, Wu J, Chen S, Li Y, Jin H, He Q, Zhu DY, Zhou Y, Hu B.
Cell Death Dis. 2022 May 14;13(5):462. doi: 10.1038/s41419-022-04888-5.
PMID: 35568723
2.
Glycoprotein nonmetastatic melanoma protein B (GNMPB) as a novel biomarker for cerebral adrenoleukodystrophy. Taghizadeh LA, King CJ, Nascene DR, Gupta AO, Orchard PJ, Higgins L, Markowski TW, Nolan EE, Furcich JW, Lund TC.
Sci Rep. 2022 May 14;12(1):7985. doi: 10.1038/s41598-022-11552-7.
PMID: 35568699
3.
A case of autoimmune glial fibrillary acidic protein astrocytopathy presenting with magnetic resonance imaging mimics of multiple sclerosis. Sakashita Y, Nozaki I, Hamaguchi T, Kimura A, Shimohata T, Ono K.
Clin Neurol Neurosurg. 2022 Apr 29;218:107272. doi: 10.1016/j.clineuro.2022.107272. Online ahead of print.
PMID: 35567834
4.
Development and application of a fast ultra-high performance liquid chromatography-trapped ion mobility mass spectrometry method for untargeted lipidomics. Merciai F, Musella S, Sommella E, Bertamino A, D’Ursi AM, Campiglia P.
J Chromatogr A. 2022 May 6;1673:463124. doi: 10.1016/j.chroma.2022.463124. Online ahead of print.
PMID: 35567813
5.
Seroprevalence of SARS-CoV-2 in a Cohort of Patients with Multiple Sclerosis under Disease-Modifying Therapies. Sancho-Saldaña A, Gil Sánchez A, Quirant-Sánchez B, Nogueras L, Peralta S, Solana MJ, González-Mingot C, Gallego Y, Quibus L, Ramo-Tello C, Presas-Rodríguez S, Martínez-Cáceres E, Torres P, Hervás JV, Valls J, Brieva L.
J Clin Med. 2022 Apr 29;11(9):2509. doi: 10.3390/jcm11092509.
PMID: 35566632
6.
The Impact of Resistance Training Program on Static Balance in Multiple Sclerosis Population: A Randomized Controlled Trial Study. Andreu-Caravaca L, Ramos-Campo DJ, Manonelles P, Chung LH, Ramallo S, Rubio-Arias JÁ.
J Clin Med. 2022 Apr 25;11(9):2405. doi: 10.3390/jcm11092405.
PMID: 35566530
7.
Synthesis and Evaluation of Serinolamide Derivatives as Sphingosine-1-Phosphate-1 (S1P1) Receptor Agonists. Park SJ, Kim J, Kim J, Kim Y, Lee EH, Kim HJ, Kim S, Kim B, Kim R, Choi JW, Park JH, Park KD.
Molecules. 2022 Apr 28;27(9):2818. doi: 10.3390/molecules27092818.
PMID: 35566164
8.
Dietary Patterns and Metabolic Disorders in Polish Adults with Multiple Sclerosis. Suliga E, Brola W, Sobaś K, Cieśla E, Jasińska E, Gołuch K, Głuszek S.
Nutrients. 2022 May 4;14(9):1927. doi: 10.3390/nu14091927.
PMID: 35565893
9.
Vitamin D: Before, during and after Pregnancy: Effect on Neonates and Children. Mansur JL, Oliveri B, Giacoia E, Fusaro D, Costanzo PR.
Nutrients. 2022 May 1;14(9):1900. doi: 10.3390/nu14091900.
PMID: 35565867 Review.
10.
The Big Five Personality Traits and Positive Orientation in Polish Adults with Multiple Sclerosis: The Role of Meaning in Life. Szcześniak M, Potemkowski A, Brola W, Kroplewski Z, Szałachowski RR, Zak M, Wilski M, Sobolewski P, Bartosik-Psujek H, Kapica-Topczewska K, Tarasiuk J, Czarnowska A, Kułakowska A, Zakrzewska-Pniewska B, Kubicka-Bączyk K, Morawiec N, Adamczyk-Sowa M, Stępień A, Zaborski J, Ratajczak A, Ratajczak M.
Int J Environ Res Public Health. 2022 Apr 29;19(9):5426. doi: 10.3390/ijerph19095426.
PMID: 35564821
11.
Methodological Investigation of Time Perspective Scoring and Quality of Life among Individuals with Multiple Sclerosis. Carl E, Shevorykin A, Liskiewicz A.
Int J Environ Res Public Health. 2022 Apr 21;19(9):5038. doi: 10.3390/ijerph19095038.
PMID: 35564432
12.
Vitamin D Fortification of Milk Would Increase Vitamin D Intakes in the Australian Population, but a More Comprehensive Strategy Is Required. Dunlop E, James AP, Cunningham J, Rangan A, Daly A, Kiely M, Nowson CA, Adorno P, Atyeo P, Black LJ.
Foods. 2022 May 9;11(9):1369. doi: 10.3390/foods11091369.
PMID: 35564091
13.
Glatiramer Acetate Immunomodulation: Evidence of Neuroprotection and Cognitive Preservation. Kasindi A, Fuchs DT, Koronyo Y, Rentsendorj A, Black KL, Koronyo-Hamaoui M.
Cells. 2022 May 7;11(9):1578. doi: 10.3390/cells11091578.
PMID: 35563884 Review.
14.
miR-150-5p and let-7b-5p in Blood Myeloid Extracellular Vesicles Track Cognitive Symptoms in Patients with Multiple Sclerosis. Scaroni F, Visconte C, Serpente M, Golia MT, Gabrielli M, Huiskamp M, Hulst HE, Carandini T, De Riz M, Pietroboni A, Rotondo E, Scarpini E, Galimberti D, Teunissen CE, van Dam M, de Jong BA, Fenoglio C, Verderio C.
Cells. 2022 May 5;11(9):1551. doi: 10.3390/cells11091551.
PMID: 35563859
15.
RhoA Signaling in Neurodegenerative Diseases. Schmidt SI, Blaabjerg M, Freude K, Meyer M.
Cells. 2022 May 1;11(9):1520. doi: 10.3390/cells11091520.
PMID: 35563826 Review.
16.
Proteomics in Multiple Sclerosis: The Perspective of the Clinician. Sandi D, Kokas Z, Biernacki T, Bencsik K, Klivényi P, Vécsei L.
Int J Mol Sci. 2022 May 5;23(9):5162. doi: 10.3390/ijms23095162.
PMID: 35563559 Review.
17.
Complex N-Linked Glycosylation: A Potential Modifier of Niemann-Pick Disease, Type C1 Pathology. Cawley NX, Lyons AT, Abebe D, Luke R, Yerger J, Telese R, Wassif CA, Bailey-Wilson JE, Porter FD.
Int J Mol Sci. 2022 May 3;23(9):5082. doi: 10.3390/ijms23095082.
PMID: 35563467
18.
Exploring the Pro-Phagocytic and Anti-Inflammatory Functions of PACAP and VIP in Microglia: Implications for Multiple Sclerosis. Jansen MI, Thomas Broome S, Castorina A.
Int J Mol Sci. 2022 Apr 26;23(9):4788. doi: 10.3390/ijms23094788.
PMID: 35563181 Review.
19.
MicroRNA Alteration, Application as Biomarkers, and Therapeutic Approaches in Neurodegenerative Diseases. Nguyen TPN, Kumar M, Fedele E, Bonanno G, Bonifacino T.
Int J Mol Sci. 2022 Apr 25;23(9):4718. doi: 10.3390/ijms23094718.
PMID: 35563107 Review.
20.
Adhesion Molecule Profile and the Effect of Anti-VLA-4 mAb Treatment in Experimental Autoimmune Encephalomyelitis, a Mouse Model of Multiple Sclerosis. Pyka-Fościak G, Lis GJ, Litwin JA.
Int J Mol Sci. 2022 Apr 22;23(9):4637. doi: 10.3390/ijms23094637.
PMID: 35563027
21.
Molecular Biomarkers and Their Implications for the Early Diagnosis of Selected Neurodegenerative Diseases. Doroszkiewicz J, Groblewska M, Mroczko B.
Int J Mol Sci. 2022 Apr 21;23(9):4610. doi: 10.3390/ijms23094610.
PMID: 35563001 Review.
2022 May 14
1.
Ethanol Inhibits the Metabolism of the Multiple Sclerosis Drug Dimethyl Fumarate to its Active Metabolite and Decreases Brain Exposure. Yang B, Parker RB, Meibohm B, Srivastava A, Temrikar ZH, Laizure SC.
FASEB J. 2022 May;36 Suppl 1. doi: 10.1096/fasebj.2022.36.S1.R2772.
PMID: 35556785
2.
Integrative therapies for amyotrophic lateral sclerosis disease using dynamic physiological systems. Nnake I, Tulp OL, Einstein GP.
FASEB J. 2022 May;36 Suppl 1. doi: 10.1096/fasebj.2022.36.S1.R2497.
PMID: 35556768
3.
Mechanistic Insights of Sulfonamide-Based NLRP3 Inhibitors for the Treatment of Neurodegenerative Diseases. Blevins H, Xu Y, Biby S, Zhang S.
FASEB J. 2022 May;36 Suppl 1. doi: 10.1096/fasebj.2022.36.S1.R3734.
PMID: 35556583
4.
To each their own: Disparate abilities of Nrf2 activators to protect against various electrophilic and oxidative insults. Biesterveld LM, Eggler AL.
FASEB J. 2022 May;36 Suppl 1. doi: 10.1096/fasebj.2022.36.S1.R2381.
PMID: 35556579
5.
Health-Related Quality of Life with Diroximel Fumarate in Patients with Relapsing Forms of Multiple Sclerosis: Findings from Qualitative Research Using Patient Interviews. Gudesblatt M, Roman C, Singer BA, Schmidt H, Thomas J, Shankar SL, Lyons J, Kapadia S.
Adv Ther. 2022 May 13. doi: 10.1007/s12325-022-02164-8. Online ahead of print.
PMID: 35556227
6.
Spontaneous Cardiovagal Baroreflex Sensitivity in Females with Multiple Sclerosis. Trotter CE, Jarrard CP, Smith AD, Knoll HD, Young BE, Huang M, Davis SL.
FASEB J. 2022 May;36 Suppl 1. doi: 10.1096/fasebj.2022.36.S1.L7755.
PMID: 35555654
7.
Characterization of structural features driving promiscuous ligand binding in GMCSF. Cui J, Lisi G.
FASEB J. 2022 May;36 Suppl 1. doi: 10.1096/fasebj.2022.36.S1.L7962.
PMID: 35555475
8.
Role of the Gβ5/R7-RGS complex in the regulation of pain transmission in sensory ganglia. Degner KN, Zhang JH, Pandey M, Smerin G, Fikse E, Simonds W.
FASEB J. 2022 May;36 Suppl 1. doi: 10.1096/fasebj.2022.36.S1.R2464.
PMID: 35554303
9.
Neuroimmunomodulatory balance between pro and anti-inflammatory cytokines regulate m-CoV induced alteration of gap junction protein Cx43. Kasle G, Das Sarma J.
FASEB J. 2022 May;36 Suppl 1. doi: 10.1096/fasebj.2022.36.S1.R2933.
PMID: 35554275
10.
Multiple pathways for Fig4 contributions to cellular homeostasis in yeast. Khan I, Reeves HE, Darbro CS, Hall HS, Strunk BS.
FASEB J. 2022 May;36 Suppl 1. doi: 10.1096/fasebj.2022.36.S1.R5841.
PMID: 35554119
11.
Defining Dopamine-Mediated Changes in NLRP1, NLRC5, NLRC4, and AIM2 Inflammasomes in Human Myeloid Cells. Canagarajah J, Matt S, Gaskill PJ.
FASEB J. 2022 May;36 Suppl 1. doi: 10.1096/fasebj.2022.36.S1.R3191.
PMID: 35554038
12.
Potential role of BAY11-7082, a NF-κB blocker inhibiting experimental autoimmune encephalomyelitis in C57BL/6J mice via declining NLRP3 inflammasomes. Lang Y, Chu F, Liu L, Zheng C, Li C, Shen D, Liu S, Zhang W, Cui L, Zhu J.
Clin Exp Immunol. 2022 May 12;207(3):378-386. doi: 10.1093/cei/uxab022.
PMID: 35553640
13.
Seroconversion following COVID-19 vaccination: can we optimize protective response in CD20-treated individuals? Baker D, MacDougall A, Kang AS, Schmierer K, Giovannoni G, Dobson R.
Clin Exp Immunol. 2022 May 12;207(3):263-271. doi: 10.1093/cei/uxab015.
PMID: 35553629
14.
Building a Distributed Research Network for Undergraduate Opportunities in Molecular Biochemistry. Prokop JW, Underwood A, Faber W, Wilstermann A, Shor A, Stenger C, Cline S, Morris M.
FASEB J. 2022 May;36 Suppl 1. doi: 10.1096/fasebj.2022.36.S1.R4308.
PMID: 35552883
15.
Antimicrobial Triclosan (TCS) Increases Production of Interleukin 1 beta (IL-1β) in Human Immune Cells. Wilburn WJ, Whalen M.
FASEB J. 2022 May;36 Suppl 1. doi: 10.1096/fasebj.2022.36.S1.0R880.
PMID: 35552854
16.
Sex differences in the genetic architecture of cognitive resilience to Alzheimer’s disease. Eissman JM, Dumitrescu L, Mahoney ER, Smith AN, Mukherjee S, Lee ML, Scollard P, Choi SE, Bush WS, Engelman CD, Lu Q, Fardo DW, Trittschuh EH, Mez J, Kaczorowski CC, Hernandez Saucedo H, Widaman KF, Buckley RF, Properzi MJ, Mormino EC, Yang HS, Harrison TM, Hedden T, Nho K, Andrews SJ, Tommet D, Hadad N, Sanders RE, Ruderfer DM, Gifford KA, Zhong X, Raghavan NS, Vardarajan BN; Alzheimer’s Disease Neuroimaging Initiative (ADNI); Alzheimer’s Disease Genetics Consortium (ADGC); A4 Study Team, Pericak-Vance MA, Farrer LA, Wang LS, Cruchaga C, Schellenberg GD, Cox NJ, Haines JL, Keene CD, Saykin AJ, Larson EB, Sperling RA, Mayeux R, Cuccaro ML, Bennett DA, Schneider JA, Crane PK, Jefferson AL, Hohman TJ.
Brain. 2022 May 13:awac177. doi: 10.1093/brain/awac177. Online ahead of print.
PMID: 35552371
17.
Ribosomal quality control in repeat-associated non-AUG translation of GC rich repeats. Tseng YJ, Todd PK.
FASEB J. 2022 May;36 Suppl 1. doi: 10.1096/fasebj.2022.36.S1.R4099.
PMID: 35552311
18.
Coping Style Moderates the Effect of Pain on Depression Symptoms in Multiple Sclerosis. Bradson ML, Cadden MH, Guty ET, Riegler KE, Thomas GA, Graham-Engeland JE, Arnett PA.
Arch Clin Neuropsychol. 2022 May 12:acac025. doi: 10.1093/arclin/acac025. Online ahead of print.
PMID: 35551333
19.
Circulating neurofilament is linked with morbid obesity, renal function, and brain density. Rebelos E, Rissanen E, Bucci M, Jääskeläinen O, Honka MJ, Nummenmaa L, Moriconi D, Laurila S, Salminen P, Herukka SK, Singhal T, Nuutila P.
Sci Rep. 2022 May 12;12(1):7841. doi: 10.1038/s41598-022-11557-2.
PMID: 35551210
20.
Trained immunity in viral infections, Alzheimer’s disease and multiple sclerosis: A convergence in type I interferon signalling and IFNβ-1a. Vavougios GD, Mavridis T, Artemiadis A, Krogfelt KA, Hadjigeorgiou G.
Biochim Biophys Acta Mol Basis Dis. 2022 May 9:166430. doi: 10.1016/j.bbadis.2022.166430. Online ahead of print.
PMID: 35550850 Review.
21.
Effect of different durations of using a standing frame on the rate of hip migration in children with moderate to severe cerebral palsy: a feasibility study for a randomised controlled trial. Rapson R, King T, Morris C, Jeffery R, Mellhuish J, Stephens C, Marsden J.
Physiotherapy. 2022 Jan 29;116:42-49. doi: 10.1016/j.physio.2022.01.001. Online ahead of print.
PMID: 35550486
22.
Prognostic value of intrathecal IgM synthesis determined by various laboratory methods in patients with early multiple sclerosis – a prospective observational study. Revendova K, Zeman D, Kusnierova P, Bunganic R, Hanzlikova P, Karasova K, Volny O, Bar M.
Mult Scler Relat Disord. 2022 May 6;63:103847. doi: 10.1016/j.msard.2022.103847. Online ahead of print.
PMID: 35550481
23.
The influence of COVID-19 pandemic lockdown on the physical activity of people with multiple sclerosis. The role of online training. Matysiak M, Siger M, Walczak A, Ciach A, Jonakowski M, Stasiołek M.
Mult Scler Relat Disord. 2022 May 6;63:103843. doi: 10.1016/j.msard.2022.103843. Online ahead of print.
PMID: 35550480
24.
Cerebrospinal fluid amyloid precursor protein as a potential biomarker of fatigue in multiple sclerosis: A pilot study. Johansson K, Wasling P, Novakova L, Sjödin S, Brinkmalm A, Brinkmalm G, Blennow K, Zetterberg H, Axelsson M.
Mult Scler Relat Disord. 2022 May 6;63:103846. doi: 10.1016/j.msard.2022.103846. Online ahead of print.
PMID: 35550479
25.
Introduction of loxP sites by electroporation in the mouse genome; a simple approach for conditional allele generation in complex targeting loci. Bernas G, Ouellet M, Barrios A, Jamann H, Larochelle C, Lévy É, Schmouth JF.
BMC Biotechnol. 2022 May 12;22(1):14. doi: 10.1186/s12896-022-00744-8.
PMID: 35549895
26.
Two years of COVID-19 in the MS community: What have we learnt so far? Zabalza A, Thompson AJ, Montalban X.
Mult Scler. 2022 May 13:13524585221099844. doi: 10.1177/13524585221099844. Online ahead of print.
PMID: 35549532 No abstract available.
27.
Long-term trajectories of employment status, workhours and disability support pension status, after a first episode of CNS demyelination. Zarghami A, van der Mei I, Hussain MA, Claflin SB, Bessing B, Simpson-Yap S, Ponsonby AL, Lechner-Scott J, Broadley S, Blizzard L, Taylor BV; AusLong Investigator Group.
Mult Scler. 2022 May 13:13524585221089900. doi: 10.1177/13524585221089900. Online ahead of print.
PMID: 35549477
28.
[Periodic plasmapheresis as maintenance treatment in relapsing-remitting multiple sclerosis, a new therapeutic line? A case report]. Lafuente-Gómez G, Anaya-Fernández Lomana F, Gómez-Roldós A, García-Domínguez JM, Lozano-Ros A, Cuello JP, Higueras-Hernández Y, Meldaña-Rivera A, Goicochea-Briceño H, Leal-Hidalgo R, De Miguel-Sánchez de Puerta CJ, Martínez-Ginés ML.
Rev Neurol. 2022 May 16;74(10):340-342. doi: 10.33588/rn.7410.2021184.
PMID: 35548915 Spanish.
29.
MicroRNAs as T Lymphocyte Regulators in Multiple Sclerosis. Wang L, Liang Y.
Front Mol Neurosci. 2022 Apr 25;15:865529. doi: 10.3389/fnmol.2022.865529. eCollection 2022.
PMID: 35548667 Free PMC article. Review.
30.
Integrating Lipidomics and Transcriptomics Reveals the Crosstalk Between Oxidative Stress and Neuroinflammation in Central Nervous System Demyelination. Zhao ZJ, Zheng RZ, Wang XJ, Li TQ, Dong XH, Zhao CY, Li XY.
Front Aging Neurosci. 2022 Apr 25;14:870957. doi: 10.3389/fnagi.2022.870957. eCollection 2022.
PMID: 35547618 Free PMC article.
31.
Acute Multiple Sclerosis Exacerbation After Vaccination With the Johnson & Johnson COVID-19 Vaccine: Novel Presentation and First Documented Case Report. Al-Midfai Y, Kujundzic W, Uppal S, Oakes D, Giezy S.
Cureus. 2022 Apr 10;14(4):e24017. doi: 10.7759/cureus.24017. eCollection 2022 Apr.
PMID: 35547449 Free PMC article.
32.
A Rare Case of Balo Concentric Sclerosis, a Subtype of Tumefactive Multiple Sclerosis, in a 40-Year-Old Male: Case Report. Al Ashi AK, Meray V, Aziz AM.
Cureus. 2022 Apr 11;14(4):e24033. doi: 10.7759/cureus.24033. eCollection 2022 Apr.
PMID: 35547427 Free PMC article.
33.
Superinfection of an Obstructive Appendiceal Mucocele: A Case Report. Charalambous C, Charalambous T, Nikitaras A, Christodoulou P.
Cureus. 2022 Apr 9;14(4):e23974. doi: 10.7759/cureus.23974. eCollection 2022 Apr.
PMID: 35547418 Free PMC article.
34.
Effect of Honey Bee Venom on Experimental Autoimmune Encephalomyelitis (EAE) as a Model for Multiple Sclerosis (MS). Jelodar S, Zare Mirakabadi A, Oryan S, Mohammadnejad L.
Arch Razi Inst. 2021 Dec 30;76(6):1727-1733. doi: 10.22092/ARI.2021.126291.1342. eCollection 2021 Dec.
PMID: 35546974 Free PMC article.
2022 May 12
1.
Prioritization of risk genes in multiple sclerosis by a refined Bayesian framework followed by tissue-specificity and cell type feature assessment. Liu A, Manuel AM, Dai Y, Zhao Z.
BMC Genomics. 2022 May 11;23(Suppl 4):362. doi: 10.1186/s12864-022-08580-y.
PMID: 35545758
2.
A multi-step genomic approach prioritized TBKBP1 gene as relevant for multiple sclerosis susceptibility. Sorosina M, Barizzone N, Clarelli F, Anand S, Lupoli S, Salvi E, Mangano E, Bordoni R, Roostaei T, Mascia E, Zuccalà M, Vecchio D, Cavalla P, Santoro S, Ferrè L, Zollo A; PROGEMUS, Barlassina C, Cusi D, Martinelli V, Comi G, Leone M, Filippi M, Patsopoulos NA, De Jager PL, De Bellis G, Esposito F, D’Alfonso S, Martinelli Boneschi F.
J Neurol. 2022 May 12. doi: 10.1007/s00415-022-11109-8. Online ahead of print.
PMID: 35545683
3.
Isolated sixth nerve palsy: a rare first presentation in multiple sclerosis. Lim QX, Ahmed F, Patel S.
BMJ Case Rep. 2022 May 11;15(5):e247928. doi: 10.1136/bcr-2021-247928.
PMID: 35545312
4.
Enhancement of Regnase-1 expression with stem loop-targeting antisense oligonucleotides alleviates inflammatory diseases. Tse KM, Vandenbon A, Cui X, Mino T, Uehata T, Yasuda K, Sato A, Tsujimura T, Hia F, Yoshinaga M, Kinoshita M, Okuno T, Takeuchi O.
Sci Transl Med. 2022 May 11;14(644):eabo2137. doi: 10.1126/scitranslmed.abo2137. Epub 2022 May 11.
PMID: 35544597
5.
Factors Associated With Serological Response to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Treated With Rituximab. Tolf A, Wiberg A, Müller M, Nazir FH, Pavlovic I, Laurén I, Mangsbo S, Burman J.
JAMA Netw Open. 2022 May 2;5(5):e2211497. doi: 10.1001/jamanetworkopen.2022.11497.
PMID: 35544139
6.
Myelodysplastic syndrome in an alemtuzumab-treated multiple sclerosis patient. Kim JH, Park S, Kim W.
Neurol Sci. 2022 May 11. doi: 10.1007/s10072-022-06124-6. Online ahead of print.
PMID: 35543831 No abstract available.
7.
Basal metabolic rate and risk of multiple sclerosis: a Mendelian randomization study. Liu C, Lu Y, Chen J, Qiu W, Zhan Y, Liu Z.
Metab Brain Dis. 2022 May 11. doi: 10.1007/s11011-022-00973-y. Online ahead of print.
PMID: 35543713
8.
Conservation and divergence of myelin proteome and oligodendrocyte transcriptome profiles between humans and mice. Gargareta VI, Reuschenbach J, Siems SB, Sun T, Piepkorn L, Mangana C, Späte E, Goebbels S, Huitinga I, Möbius W, Nave KA, Jahn O, Werner HB.
Elife. 2022 May 11;11:e77019. doi: 10.7554/eLife.77019.
PMID: 35543322
9.
Association of Maintenance Intravenous Immunoglobulin With Prevention of Relapse in Adult Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease. Chen JJ, Huda S, Hacohen Y, Levy M, Lotan I, Wilf-Yarkoni A, Stiebel-Kalish H, Hellmann MA, Sotirchos ES, Henderson AD, Pittock SJ, Bhatti MT, Eggenberger ER, Di Nome M, Kim HJ, Kim SH, Saiz A, Paul F, Dale RC, Ramanathan S, Palace J, Camera V, Leite MI, Lam BL, Bennett JL, Mariotto S, Hodge D, Audoin B, Maillart E, Deschamps R, Pique J, Flanagan EP, Marignier R.
JAMA Neurol. 2022 May 1;79(5):518-525. doi: 10.1001/jamaneurol.2022.0489.
PMID: 35377395
2022 May 11
1.
Guilty by association: Epstein-Barr virus in multiple sclerosis. Bar-Or A, Banwell B, Berger JR, Lieberman PM.
Nat Med. 2022 May 10. doi: 10.1038/s41591-022-01823-1. Online ahead of print.
PMID: 35538259 No abstract available.
2.
Priming of microglia by type II interferon is lasting and resistant to modulation by interleukin-10 in situ. Hemmerich M, Malorny N, Lewen A, Hollnagel JO, Chausse B, Kann O.
J Neuroimmunol. 2022 Apr 28;368:577881. doi: 10.1016/j.jneuroim.2022.577881. Online ahead of print.
PMID: 35537331
3.
Exploring steroid tapering in patients with neuromyelitis optica spectrum disorder treated with satralizumab in SAkuraSky: A case series. Yamamura T, Araki M, Fujihara K, Okuno T, Misu T, Guo YC, Hemingway C, Matsushima J, Sugaya N, Yamashita M, von Büdingen HC, Miyamoto K.
Mult Scler Relat Disord. 2022 Mar 25;61:103772. doi: 10.1016/j.msard.2022.103772. Online ahead of print.
PMID: 35537314 No abstract available.
4.
Is there a link between neuropathic pain and constipation in NMOSD and MOGAD? Results from an online patient survey and possible clinical implications. Lotan I, Romanow G, Levy M, Kister I.
Mult Scler Relat Disord. 2022 Apr 26;63:103825. doi: 10.1016/j.msard.2022.103825. Online ahead of print.
PMID: 35537276
5.
Effect of Electrode Montage on 500-Hz Tone Burst Evoked Masseter Vestibular Evoked Myogenic Potential. Thirusangu VP, Sinha SK.
Am J Audiol. 2022 May 10:1-8. doi: 10.1044/2022_AJA-22-00016. Online ahead of print.
PMID: 35537126
6.
MicroRNAs in oligodendrocyte development and remyelination. Ngo C, Kothary R.
J Neurochem. 2022 May 10. doi: 10.1111/jnc.15618. Online ahead of print.
PMID: 35536759 Review.
7.
Age-dependent grey matter demyelination is associated with leptomeningeal neutrophil accumulation. Zuo M, Fettig NM, Bernier LP, Pössnecker E, Spring S, Pu A, Ma XI, Lee DS, Ward LA, Sharma A, Kuhle J, Sled JG, Pröbstel AK, MacVicar BA, Osborne LC, Gommerman JL, Ramaglia V.
JCI Insight. 2022 May 10:e158144. doi: 10.1172/jci.insight.158144. Online ahead of print.
PMID: 35536649
8.
Syncytin-1 nonfusogenic activities modulate inflammation and contribute to preeclampsia pathogenesis. Bu C, Wang Z, Ren Y, Chen D, Jiang SW.
Cell Mol Life Sci. 2022 May 10;79(6):290. doi: 10.1007/s00018-022-04294-2.
PMID: 35536515 Review.
9.
Associations between corpus callosum damage, clinical disability, and surface-based homologous inter-hemispheric connectivity in multiple sclerosis. Russo AW, Stockel KE, Tobyne SM, Ngamsombat C, Brewer K, Nummenmaa A, Huang SY, Klawiter EC.
Brain Struct Funct. 2022 May 10. doi: 10.1007/s00429-022-02498-7. Online ahead of print.
PMID: 35536387
10.
Aquaporin-4 prevents exaggerated astrocytosis and structural damage in retinal inflammation. Maisam Afzali A, Stüve L, Pfaller M, Aly L, Steiger K, Knier B, Korn T.
J Mol Med (Berl). 2022 May 10. doi: 10.1007/s00109-022-02202-6. Online ahead of print.
PMID: 35536323
11.
Single-cell profiling reveals periventricular CD56bright NK cell accumulation in multiple sclerosis. Rodríguez-Lorenzo S, van Olst L, Rodriguez-Mogeda C, Kamermans A, van der Pol SMA, Rodríguez E, Kooij G, de Vries HE.
Elife. 2022 May 10;11:e73849. doi: 10.7554/eLife.73849. Online ahead of print.
PMID: 35536009
12.
Neuroprotection and neuroregeneration: roles for the white matter. Baldassarro VA, Stanzani A, Giardino L, Calzà L, Lorenzini L.
Neural Regen Res. 2022 Nov;17(11):2376-2380. doi: 10.4103/1673-5374.335834.
PMID: 35535874 Review.
13.
Multidisciplinary neurocutaneous syndrome clinics: a systematic review and institutional experience. Grossen A, Gavula T, Chrusciel D, Evans A, McNall-Knapp R, Taylor A, Fossey B, Brakefield M, Carter C, Schwartz N, Gross N, Jea A, Desai V.
Neurosurg Focus. 2022 May;52(5):E2. doi: 10.3171/2022.2.FOCUS21776.
PMID: 35535824
14.
Smarter adaptive platform clinical trials in neurology: a showcase for UK innovation. Mehta AR, Pal S, Chataway J, Carpenter JR, Parmar MKB, Chandran S.
Brain. 2022 May 10:awac169. doi: 10.1093/brain/awac169. Online ahead of print.
PMID: 35535817 No abstract available.
15.
Transplant Tolerance, Not Only Clonal Deletion. Hall BM, Verma ND, Tran GT, Hodgkinson SJ.
Front Immunol. 2022 Apr 21;13:810798. doi: 10.3389/fimmu.2022.810798. eCollection 2022.
PMID: 35529847 Free PMC article. Review.
2022 May 10
1.
The impact of the gut microbiome on extra-intestinal autoimmune diseases. Miyauchi E, Shimokawa C, Steimle A, Desai MS, Ohno H.
Nat Rev Immunol. 2022 May 9. doi: 10.1038/s41577-022-00727-y. Online ahead of print.
PMID: 35534624 Review.
2.
Multiple sclerosis genetic and non-genetic factors interact through the transient transcriptome. Umeton R, Bellucci G, Bigi R, Romano S, Buscarinu MC, Reniè R, Rinaldi V, Pizzolato Umeton R, Morena E, Romano C, Mechelli R, Salvetti M, Ristori G.
Sci Rep. 2022 May 9;12(1):7536. doi: 10.1038/s41598-022-11444-w.
PMID: 35534508
3.
Role of Chitinase 3-like 1 as a Biomarker in Multiple Sclerosis: A Systematic Review and Meta-analysis. Floro S, Carandini T, Pietroboni AM, De Riz MA, Scarpini E, Galimberti D.
Neurol Neuroimmunol Neuroinflamm. 2022 May 9;9(4):e1164. doi: 10.1212/NXI.0000000000001164. Print 2022 Jul.
PMID: 35534236
4.
Bladder stone causing vesicovaginal fistula and migration into the vagina. Sonawane P, Sathish V, Nadeem M.
BMJ Case Rep. 2022 May 9;15(5):e249463. doi: 10.1136/bcr-2022-249463.
PMID: 35534044
5.
Deuterium metabolic imaging and hyperpolarized 13C-MRI of the normal human brain at clinical field strength reveals differential cerebral metabolism. Kaggie JD, Khan AS, Matys T, Schulte RF, Locke MJ, Grimmer A, Frary A, Menih IH, Latimer E, Graves MJ, McLean MA, Gallagher FA.
Neuroimage. 2022 May 6:119284. doi: 10.1016/j.neuroimage.2022.119284. Online ahead of print.
PMID: 35533826
6.
miRNAs in multiple sclerosis: A clinical approach. Minutti-Zanella C, Bojalil-Álvarez L, García-Villaseñor E, López-Martínez B, Pérez-Turrent M, Murrieta-Álvarez I, Ruiz-Delgado GJ, Argüelles GJR.
Mult Scler Relat Disord. 2022 Apr 30;63:103835. doi: 10.1016/j.msard.2022.103835. Online ahead of print.
PMID: 35533548 Review.
7.
Differential antibody response to COVID-19 vaccines across immunomodulatory therapies for multiple sclerosis. Satyanarayan S, Safi N, Sorets T, Filomena S, Zhang Y, Klineova S, Fabian M, Horng S, Tankou S, Miller A, Krieger S, Lublin F, Sumowski J, Katz Sand I.
Mult Scler Relat Disord. 2022 Mar 12;62:103737. doi: 10.1016/j.msard.2022.103737. Online ahead of print.
PMID: 35533419
8.
Sensitive and convenient detection of miRNA-145 using a gold nanoparticle-HCR coupled system: computational and in vitro validations. Beyrampour-Basmenj H, Pourhassan-Moghamddam M, Nakhjavani SA, Faraji N, Alivand M, Zarghami N, Talebi M, Rahmati M, Ebrahimi-Kalan A.
IEEE Trans Nanobioscience. 2022 May 9;PP. doi: 10.1109/TNB.2022.3170530. Online ahead of print.
PMID: 35533171
9.
Age-specific effects of childhood body mass index on multiple sclerosis risk. Hone L, Jacobs BM, Marshall C, Giovannoni G, Noyce A, Dobson R.
J Neurol. 2022 May 9. doi: 10.1007/s00415-022-11161-4. Online ahead of print.
PMID: 35532785
10.
Nephrogenic Systemic Fibrosis with Osseous Metaplasia in a Kidney-Pancreas Transplant Patient. de Lavillandre JLB, Buron F, Ducroux E, Kanitakis J.
Skinmed. 2022 Apr 30;20(2):145-148. eCollection 2022.
PMID: 35532771
11.
Opercular Syndrome: A Rare Presentation of Schilder’s Variant of Multiple Sclerosis. Kumar A, Pathak A, Joshi D, Chaurasia RN, Verma A, Mishra VN, Singh VK.
Neurol India. 2022 Mar-Apr;70(2):806-807. doi: 10.4103/0028-3886.344611.
PMID: 35532671 No abstract available.
12.
The relationship between processing speed and verbal and non-verbal new learning and memory in progressive multiple sclerosis. Chiaravalloti ND, DeLuca J, Salter A, Amato MP, Brichetto G, Chataway J, Dalgas U, Farrell R, Feys P, Filippi M, Freeman J, Inglese M, Meza C, Moore NB, Motl RW, Rocca MA, Sandroff BM, Cutter G, Feinstein A.
Mult Scler. 2022 May 9:13524585221088190. doi: 10.1177/13524585221088190. Online ahead of print.
PMID: 35531965
13.
Transplant Tolerance, Not Only Clonal Deletion. Hall BM, Verma ND, Tran GT, Hodgkinson SJ.
Front Immunol. 2022 Apr 21;13:810798. doi: 10.3389/fimmu.2022.810798. eCollection 2022.
PMID: 35529847 Free PMC article. Review.
14.
Age-associated impairment of T cell immunity is linked to sex-dimorphic elevation of N-glycan branching. Mkhikian H, Hayama KL, Khachikyan K, Li C, Zhou RW, Pawling J, Klaus S, Tran PQN, Ly KM, Gong AD, Saryan H, Hai JL, Grigoryan D, Lee PL, Newton BL, Raffatellu M, Dennis JW, Demetriou M.
Nat Aging. 2022 Mar;2(3):231-242. doi: 10.1038/s43587-022-00187-y. Epub 2022 Mar 18.
PMID: 35528547
15.
PRPH2-Associated Macular Dystrophy in 4 Family Members with a Novel Mutation. Choi H, Cloutier A, Lally D.
Ophthalmic Genet. 2022 Apr;43(2):235-239. doi: 10.1080/13816810.2021.2015790. Epub 2021 Dec 14.
PMID: 34906036
2022 May 08
1.
Oligodendrocyte death and myelin loss in the cuprizone model: an updated overview of the intrinsic and extrinsic causes of cuprizone demyelination. Zirngibl M, Assinck P, Sizov A, Caprariello AV, Plemel JR.
Mol Neurodegener. 2022 May 7;17(1):34. doi: 10.1186/s13024-022-00538-8.
PMID: 35526004 Review.
2.
Making remote measurement technology work in multiple sclerosis, epilepsy and depression: survey of healthcare professionals. Andrews JA, Craven MP, Lang AR, Guo B, Morriss R, Hollis C; RADAR-CNS Consortium.
BMC Med Inform Decis Mak. 2022 May 7;22(1):125. doi: 10.1186/s12911-022-01856-z.
PMID: 35525933
3.
Melatonin alleviates the immune response and improves salivary gland function in primary Sjögren’s syndrome. Liu Y, Weng X, Wei M, Yu S, Ding Y, Cheng B.
Biochem Pharmacol. 2022 May 4:115073. doi: 10.1016/j.bcp.2022.115073. Online ahead of print.
PMID: 35525327
4.
Development and validation of a simple and practical method for differentiating MS from other neuroinflammatory disorders based on lesion distribution on brain MRI. Patel J, Pires A, Derman A, Fatterpekar G, Charlson RE, Oh C, Kister I.
J Clin Neurosci. 2022 May 4;101:32-36. doi: 10.1016/j.jocn.2022.04.035. Online ahead of print.
PMID: 35525154
5.
Allostatic load index in patients with multiple sclerosis: A case-control study. Waliszewska-Prosół M, Nowakowska-Kotas M, Misiak B, Chojdak-Łukasiewicz J, Budrewicz S, Pokryszko-Dragan A.
Psychoneuroendocrinology. 2022 Apr 30;142:105788. doi: 10.1016/j.psyneuen.2022.105788. Online ahead of print.
PMID: 35525125
6.
Catching a killer: Mechanisms of programmed cell death and immune activation in Amyotrophic Lateral Sclerosis. Neel DV, Basu H, Gunner G, Chiu IM.
Immunol Rev. 2022 May 7. doi: 10.1111/imr.13083. Online ahead of print.
PMID: 35524757 Review.
7.
Correlation of Serum Levels of Interleukine-16, CCL27, Tumor Necrosis Factor-related Apoptosis-inducing Ligand, and B-cell Activating Factor with Multiple Sclerosis Severity. Kouchaki E, Akbari H, Mahmoudi F, Salehi M, Naimi E, Nikoueinejad H.
Iran J Allergy Asthma Immunol. 2022 Feb 6;21(1):27-34. doi: 10.18502/ijaai.v21i1.8610.
PMID: 35524375
2022 May 07
1.
Impact of Neuromyelitis Optica Spectrum Disorder on Quality of Life from the Patients’ Perspective: An Observational Cross-Sectional Study. Meca-Lallana JE, Gómez-Ballesteros R, Pérez-Miralles F, Forero L, Sepúlveda M, Calles C, Martínez-Ginés ML, González-Suárez I, Boyero S, Romero-Pinel L, Sempere ÁP, Meca-Lallana V, Querol L, Costa-Frossard L, Prefasi D, Maurino J.
Neurol Ther. 2022 May 6. doi: 10.1007/s40120-022-00356-6. Online ahead of print.
PMID: 35524037
2.
Longitudinal T-Cell Responses After a Third SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis on Ocrelizumab or Fingolimod. Palomares Cabeza V, Kummer LYL, Wieske L, Hagen RR, Duurland M, Konijn VAL, van Dam KPJ, Stalman EW, van de Sandt CE, Boekel L, Verstegen NJM, Steenhuis M, Rispens T, Tas SW, Wolbink G, Killestein J, Kuijpers TW, van Ham SM, Eftimov F, Brinke AT, van Kempen ZLE; Target-to-B! (T2B!) SARS-CoV-2 study group.
Neurol Neuroimmunol Neuroinflamm. 2022 May 6;9(4):e1178. doi: 10.1212/NXI.0000000000001178. Print 2022 Jul.
PMID: 35523569
3.
Effects and safety of exergaming in persons with multiple sclerosis during corticosteroid treatment: a pilot study. Ozdogar AT, Baba C, Kahraman T, Sagici O, Dastan S, Ertekin O, Ozakbas S.
Mult Scler Relat Disord. 2022 Apr 25;63:103823. doi: 10.1016/j.msard.2022.103823. Online ahead of print.
PMID: 35523062
4.
Quality of life in pediatric-onset multiple sclerosis: Different disease course, different impact, different measurement approach needed. Ow N, Karp A, Ogeil J, Dilenge ME, Sébire G, Dahan-Oliel N, Kuspinar A, Mayo NE.
Mult Scler Relat Disord. 2022 Apr 29;63:103820. doi: 10.1016/j.msard.2022.103820. Online ahead of print.
PMID: 35523061
5.
Characterization of immune profile in an aging multiple sclerosis clinic population. Keegan AP, Joshi U, Abdullah L, Paris D, Darcey T, Niedospial D, Davis LA, Crawford F, Mullan M.
Mult Scler Relat Disord. 2022 Apr 25;63:103818. doi: 10.1016/j.msard.2022.103818. Online ahead of print.
PMID: 35523060
6.
Using MS induced pluripotent stem cells to investigate MS aetiology. Fortune AJ, Fletcher JL, Blackburn NB, Young KM.
Mult Scler Relat Disord. 2022 Apr 30;63:103839. doi: 10.1016/j.msard.2022.103839. Online ahead of print.
PMID: 35523059 Review.
7.
BASAL CELL CARCINOMA AND SQUAMOUS CELL CARCINOMA IN A PATIENT TREATED WITH FINGOLIMOD FOR MULTIPLE SCLEROSIS – A CASE REPORT AND LITERATURE REVIEW. Zięba N, Gębka-Kępińska B, Sowa P.
Wiad Lek. 2022;75(3):735-741.
PMID: 35522887
8.
THE POTENTIAL ROLE OF EPSTEIN BARR VIRUS IN MULTIPLE SCLEROSIS MOLECULAR AND SEROLOGICAL STUDY. Al-Obaidi AB, Ali ZA, Rasool Almashta SA, Faisel Ghazi H.
Wiad Lek. 2022;75(3):691-696.
PMID: 35522880
9.
Targeting Physical Inactivity Using Behavioral Theory in Chronic, Disabling Diseases. Pekmezi D, Motl R.
Exerc Sport Sci Rev. 2022 May 5. doi: 10.1249/JES.0000000000000291. Online ahead of print.
PMID: 35522244
10.
Azetidine-2-Carboxylic Acid-Induced Oligodendrogliopathy: Relevance to the Pathogenesis of Multiple Sclerosis. Sobel RA, Albertelli M, Hinojoza JR, Eaton MJ, Grimes KV, Rubenstein E.
J Neuropathol Exp Neurol. 2022 May 6:nlac028. doi: 10.1093/jnen/nlac028. Online ahead of print.
PMID: 35521963
11.
Predicting disease activity in Multiple Sclerosis patients- an explainable Machine Learning approach in Mavenclad trials. Basu S, Munafo A, Ben-Amor AF, Roy S, Girard P, Terranova N.
CPT Pharmacometrics Syst Pharmacol. 2022 May 6. doi: 10.1002/psp4.12796. Online ahead of print.
PMID: 35521742
12.
Occupational Therapy-Based Energy Management Education in People with Post-COVID-19 Condition-Related Fatigue: Results from a Focus Group Discussion. Hersche R, Weise A.
Occup Ther Int. 2022 Apr 14;2022:4590154. doi: 10.1155/2022/4590154. eCollection 2022.
PMID: 35521629 Free PMC article.
13.
Independence of Urinary Symptoms and Urinary Dipstick Results in Voiders With Neurogenic Bladder. Groah S, Tractenberg RE, Frost JK, Rounds A, Ljungberg I.
Top Spinal Cord Inj Rehabil. 2022 Spring;28(2):116-128. doi: 10.46292/sci21-00006. Epub 2022 Feb 25.
PMID: 35521057
14.
Adipokine Signaling Pathways in Osteoarthritis. Zhang C, Lin Y, Yan CH, Zhang W.
Front Bioeng Biotechnol. 2022 Apr 19;10:865370. doi: 10.3389/fbioe.2022.865370. eCollection 2022.
PMID: 35519618 Free PMC article. Review.
15.
Microbiota alterations in proline metabolism impact depression. Mayneris-Perxachs J, Castells-Nobau A, Arnoriaga-Rodríguez M, Martin M, de la Vega-Correa L, Zapata C, Burokas A, Blasco G, Coll C, Escrichs A, Biarnés C, Moreno-Navarrete JM, Puig J, Garre-Olmo J, Ramos R, Pedraza S, Brugada R, Vilanova JC, Serena J, Gich J, Ramió-Torrentà L, Pérez-Brocal V, Moya A, Pamplona R, Sol J, Jové M, Ricart W, Portero-Otin M, Deco G, Maldonado R, Fernández-Real JM.
Cell Metab. 2022 May 3;34(5):681-701.e10. doi: 10.1016/j.cmet.2022.04.001.
PMID: 35508109
16.
Hepatoma Derived Growth Factor Enhances Oligodendrocyte Genesis from Subventricular Zone Precursor Cells. Li Y, Dittmann NL, Eve A, Watson S, de Almeida MMA, Footz T, Voronova A.
ASN Neuro. 2022 Jan-Dec;14:17590914221086340. doi: 10.1177/17590914221086340.
PMID: 35293825 Free PMC article.